The DOI matches its Crossref record; the references it cites are not checked yet.
Hospital-treated infectious diseases and the risk of dementia: a large, multicohort, observational study with a replication cohort
Open accessPublished version of a preprint
Abstract
Background Infections have been hypothesised to increase the risk of dementia. Existing studies have included a narrow range of infectious diseases, relied on short follow-up periods, and provided little evidence for whether the increased risk is limited to specific dementia subtypes or attributable to specific microbes rather than infection burden. We aimed to compare the risk of Alzheimer's disease and other dementias across a wide range of hospital-treated bacterial and viral infections in two large cohorts with long follow-up periods. Methods In this large, multicohort, observational study, the analysis was based on a primary cohort consisting of pooled individual-level data from three prospective cohort studies in Finland (the Finnish Public Sector study, the Health and Social Support study, and the Still Working study) and an independent replication cohort from the UK Biobank. Community-dwelling adults (≥18 years) with no dementia at study entry were included. Follow-up was until Dec 31, 2012, in the Health and Social Support study, Dec 31, 2016, in the public sector study and the Still Working study, and Feb 7, 2018, in the replication cohort. Through record linkage to national hospital inpatient registers, we ascertained exposure to 925 infectious diseases (using the International Classification of Diseases 10th Revision codes) before dementia onset, and identified incident dementia from hospital records, medication reimbursement entitlements, and death certificates. Hazard ratios (HRs) for the associations of each infectious disease or disease group (index infection) with incident dementia were assessed by use of Cox proportional hazards models. We then repeated the analysis after excluding incident dementia cases that occurred during the first 10 years after initial hospitalisation due to the index infection. Findings From March 1, 1986, to Jan 1, 2005, 260 490 people were included in the primary cohort, and from Dec 19, 2006, to Oct 1, 2010, 485 708 people were included in the replication cohort. In the primary cohort analysis based on 3 947 046 person-years at risk (median follow-up 15·4 years [IQR 9·8–21·0]), 77 108 participants had at least one hospital-treated infection before dementia onset and 2768 developed dementia. Hospitalisation for any infectious disease was associated with increased dementia risk in the primary cohort (adjusted HR [aHR] 1·48 [95% CI 1·37–1·60]) and replication cohort (2·60 [2·38-2·83]). The association remained when analyses were restricted to new dementia cases that occurred more than 10 years after infection (aHR 1·22 [95% CI 1·09–1·36] in the primary cohort, the replication cohort had insufficient follow-up data for this analysis), and when comorbidities and other dementia risk factors were considered. There was evidence of a dose-response association between the number of episodes of hospital-treated infections and dementia risk in both cohorts (p trend =0·0007). Although the greatest dementia risk was seen for central nervous system (CNS) infections versus no infection (aHR 3·01 [95% CI 2·07–4·37]), excess risk was also evident for extra-CNS infections (1·47 [1·36–1·59]). Although we found little difference in the infection-dementia association by type of infection, associations were stronger for vascular dementia than for Alzheimer's disease (aHR 2·09 [95% CI 1·59–2·75] versus aHR 1·20 [1·08–1·33] in the primary cohort and aHR 3·28 [2·65–4·04] versus aHR 1·80 [1·53–2·13] in the replication cohort). Interpretation Severe infections requiring hospital treatment are associated with long-term increased risk of dementia, including vascular dementia and Alzheimer's disease. This association is not limited to CNS infections, suggesting that systemic effects are sufficient to affect the brain. The absence of infection specificity combined with evidence of dose-response relationships between infectious disease burden and dementia risk support the hypothesis that increased dementia risk is driven by general inflammation rather than specific microbes. Funding UK Medical Research Council, US National Institute on Aging, Wellcome Trust, NordForsk, Academy of Finland, and Helsinki Institute of Life Science.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Multivariable-adjusted associations between hospital-treated infections and dementia by dementia type in the replication cohort Data are adjusted HRs (95% CIs), unless otherwise specified. Error bars are 95% CIs. Model 1 was adjusted for age (as the timescale), sex, and socioeconomic status. Numbers of participants, dementia cases, and the forest plot are for this model. Model 2 used the same adjustment criteria as model 1 and excluded participants with HIV infection; it was based on 485 453 participants (2131 [0·4%] with dementia) with complete information for analysis of any infection, 471 511 participants (2044 [0·4%] with dementia) for analysis of bacterial infections, and 400 502 participants (1322 [0·3%] with dementia) for analysis of viral infections. Model 3 used the same criteria as model 2 and additionally adjusted for alcohol drinking, smoking, body-mass index, hypertension, and diabetes; it was based on 480 842 participants (2080 [0·4%] with dementia) with complete information for analysis of any infection, 467 058 participants (1995 [0·4%] with dementia) for analysis of bacterial infections, and 397 333 participants (1304 [0·3%] with dementia) for analysis of viral infections. Model 4 used the same criteria as model 3 and additionally adjusted for apolipoprotein E genotype; it was based on 470 551 participants (2025 [0·4%] with dementia) with complete information for analysis of any infection, 457 104 participants (1945 [0·4%] with dementia) for analysis of bacterial infections, and 389 067 participants (1267 [0·3%] with dementia) for analysis of viral infections. aHR=adjusted hazard ratio. *The number of patients with dementia and viral infection was less than five for frontotemporal dementia and Parkinson's disease dementia.](https://figures.cochat.ai/paper-figures/f86bd9c5fec24e57a8e7a0035428b473/hospital-treated-infectious-diseases-and-the-risk-of-dementia-a-large-figure-3.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In one IPD meta-analysis, severe peripheral systemic infections requiring hospitalisation were linked to higher dementia risk and associations persisted after adjustment for age, sex, SES, health behaviours, BMI, hypertension, diabetes and APOE genotype (HR 1·22,1·09-1·36). (337)”
From Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024) · cites this paper as [337]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies have demonstrated that a proinflammatory state (148–150), inflammatory disease (e.g., rheumatoid arthritis) (151), and immune challenges (e.g., acute infection) (152, 153) all increase the risk for dementia over multiple decades.”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [152]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, a large-scale epidemiological study demonstrated that infectious diseases, including pulmonary infections, increase the risk of AD and PD dementia (PDD).266,267”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [267]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Accumulating evidence suggests alpha-herpesviruses (i.e., HSV-1, HSV-2 and VZV) may increase risk for all-cause dementia.”
From What would it take to prove that a chronic infection is a causal agent in Alzheimer’s disease? (2025) · cites this paper as [24]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“while HSV-1 has additionally been related to increased risk of all-cause dementia, AD, vascular dementia, and other dementias, with antivirals decreasing this risk [23,24].”
From What would it take to prove that a chronic infection is a causal agent in Alzheimer’s disease? (2025) · cites this paper as [24]
Experimental — accuracy not yet measured
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 53 · Cited by 197
Metadata
- Authors
- Sipilä, P. N., Heikkilä, N., Lindbohm, J. V., Hakulinen, C., Vahtera, J., Elovainio, M., Suominen, S., Väänänen, A., Koskinen, A., Nyberg, S. T., Pentti, J., Strandberg, T. E., & Kivimäki, M.
- Affiliations
- University of Helsinki (FI)
- University of Turku (FI)
- Finnish Institute of Occupational Health (FI)
- Helsinki University Hospital (FI)
- Corresponding author
- Sipilä, Pyry N
- ORCID
- Venue
- The Lancet Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2021-11
- Volume
- 21
- Issue
- 11
- Pages
- 1557-1567
- ISSN
- 1473-3099 (ISSN-L)
- PMC
- PMC8592915
- OpenAlex
- W3175399582
- Cited by
- 197
- References
- 53
- Citations by year
- 2026: 46 · 2025: 40 · 2024: 51 · 2023: 36 · 2022: 16 · 2021: 8
- FWCI
- 20.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- The Lancet Infectious Diseases (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UTUPub (University of Turku) (submittedVersion, cc-by-nc-nd)
- Diva portal (Dalarna University Library) (submittedVersion, other-oa)
- UCL Discovery (University College London) (submittedVersion)
- Työväentutkimus Vuosikirja (submittedVersion)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- UTUPub (University of Turku) (submittedVersion)
- Funders
- Wellcome Trust (221854/Z/20/Z, 14801)
- Nordforsk
- Academy of Finland (329202, 329224, 321409, 329240, 311492, 310591)
- National Institute on Aging (R01AG056477)
- Helsinki Institute of Life Science, Helsingin Yliopisto (H970)
- Alkoholitutkimussäätiö
- Medical Research Council (R024227 /1, S011676/1)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- dementia risk, infectious diseases, bacterial infection, viral infection, Alzheimer's disease, dementia subtypes, infection burden, hospitalization, replication cohort, UK Biobank, community-dwelling adults, long-term follow-up, inpatient medical records, data linkage, causal inference, confounding
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Communicable Diseases, Dementia, Female, Humans, Male, Middle Aged, Risk Factors, Cohort Studies, Proportional Hazards Models, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hospital-treated infectious diseases and the risk of dementia: a large, multicohort, observational study with a replication cohort. https://app.cochat.ai/papers/10.1016/s1473-3099(21)00144-4
- The paper
- Sipilä, P. N., Heikkilä, N., Lindbohm, J. V., Hakulinen, C., Vahtera, J., Elovainio, M., Suominen, S., Väänänen, A., Koskinen, A., Nyberg, S. T., Pentti, J., Strandberg, T. E., & Kivimäki, M. (2021). Hospital-treated infectious diseases and the risk of dementia: a large, multicohort, observational study with a replication cohort. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(21)00144-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.